Quantcast

Latest Seattle Cancer Care Alliance Stories

2009-03-09 08:47:00

Distinguished Leadership Dedicated to Finding the Most Effective Means to Provide Health Care Access to Millions of Patients Who Seek Assistance Nationwide WASHINGTON, March 9 /PRNewswire-USNewswire/ -- The National Patient Advocate Foundation (NPAF) - a national, non-profit organization dedicated to the mission of creating avenues of improved patient access to health care through public policy reform at the state and federal levels - announced this month the election of four new Executive...

2009-02-18 08:00:00

NCCN announces new modifications to the NCCN Guidelines for Colon and Rectal Cancers. Important additions include a new survivorship section, new indications for cetuximab as it relates to KRAS gene testing, and recommendations on how to re-evaluate patients initially presenting with unresectable disease. Colorectal cancer remains the third most frequently diagnosed cancer in men and women in the United States FORT WASHINGTON, Pa., Feb. 18 /PRNewswire-USNewswire/ -- The National...

2009-02-16 10:00:00

Updated guidelines for physicians that represent best practices for using magnetic resonance imaging (MRI) to newly diagnose breast cancer and to make treatment decisions for breast cancer were published today in the Journal of the National Comprehensive Cancer Network. Breast radiologists and surgeons at the Seattle Cancer Care Alliance (SCCA) and the Roswell Park Cancer Institute in Buffalo, N.Y. authored the paper upon which the guidelines are based. The SCCA breast imaging program led by...

2009-01-22 10:15:00

SEATTLE, Jan. 22 /PRNewswire/ -- Fred Hutchinson Cancer Research Center's stem-cell transplant program at the Seattle Cancer Care Alliance (SCCA) was one of only two transplant programs nationwide that consistently outperformed the expected one-year survival rate for unrelated donor transplants, according to an independent report that assessed 122 transplant centers over a five-year period. The Center for International Blood and Marrow Transplant Registry examined the survival rates...

2009-01-15 09:15:00

NCCN recently received a $4 million research grant from Wyeth Pharmaceuticals to evaluate the safety and effectiveness of temsirolimus in the treatment of solid tumors. Temsirolimus is currently approved to treat advanced renal cell carcinoma (RCC). This grant is the largest research award received by NCCN to date. Investigators from NCCN Member Institutions are eligible to apply for the research funding. FORT WASHINGTON, Pa., Jan. 15 /PRNewswire-USNewswire/ -- The National Comprehensive...

2008-12-01 15:15:50

A new method of characterizing breast lesions found during magnetic resonance imaging could result in fewer biopsies of benign tumors, U.S. researchers said. Dr. Wendy DeMartini and colleagues in the breast imaging department at the Seattle Cancer Care Alliance developed a preliminary statistical model that breast radiologists could eventually use when deciding whether a lesion found on breast MRI is likely to be malignant or benign. The researchers reviewed almost 2,600 breast MRI exams...

2008-10-21 12:00:33

Fitch Ratings has assigned an 'A+' rating to the expected issuance of approximately $90 million Washington Health Care Facilities Authority revenue and refunding bonds series 2008 on behalf of Seattle Cancer Care Alliance (SCCA). The Rating Outlook is Stable. The series 2008 bonds are expected to be structured as traditional fixed rate bonds. Proceeds from the series 2008 financing will be used to: refinance existing series 2001 and series 2005 bonds, reimburse for prior year capital...

2008-10-07 09:00:14

The National Comprehensive Cancer Network (NCCN), Abraxis BioScience (NASDAQ:ABII), and AstraZeneca (NYSE:AZN) today announced that they have entered into a collaboration to conduct multiple investigator-initiated studies of Abraxis BioScience's anti-cancer drug ABRAXANE(R) for Injectable Suspension (paclitaxel protein-bound particles for injectable suspension) (albumin bound), which is based on the company's proprietary tumor targeting technology known as the nab(TM) platform. The NCCN...

2008-09-21 12:00:25

SEATTLE, Sept. 21 /PRNewswire/ -- For women whose breast cancer has spread to their lymph nodes, a magnetic resonance imaging (MRI) scan could replace exploratory surgery as the method for determining whether those women need radiation therapy to treat their disease, according to a study to be presented during the annual meeting of the American Society for Therapeutic Radiology and Oncology (ASTRO) which opens today in Boston. In a retrospective study of 167 patients who underwent...

2008-09-16 12:00:00

PHILADELPHIA, Sept. 16 /PRNewswire/ -- A panel of leading breast cancer experts has identified and prioritized 12 late-stage, or Phase 3, breast cancer research studies, from a total of more than 515 currently underway, with the greatest potential to improve treatment and survival. The 21 experts, all members of the Coalition of Cancer Cooperative Group's Scientific Leadership Council (SLC) in Breast Cancer outlined their consensus -- Research Priorities in Breast Cancer: Recommendations...


Word of the Day
glogg
  • Scandinavian punch made of claret and aquavit with spices and raisins and orange peel and sugar.
This word comes from the Swedish 'glogg,' which is an alteration of 'glodgat,' mulled (wine).
Related